The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Apr. 15, 2021
Applicants:
Astrazeneca Ab, Södertälje, SE;
Ionis Pharmaceuticals, Inc., Carlsbad, CA (US);
Inventors:
Brett P. Monia, Encinitas, CA (US);
Thazha P. Prakash, Carlsbad, CA (US);
Garth A. Kinberger, San Diego, CA (US);
Richard Lee, Oceanside, CA (US);
Punit P. Seth, Carlsbad, CA (US);
Shalini Andersson, Södertälje, SE;
Eva Carina Ämmälä, Mölndal, SE;
Daniel Laurent Knerr, Mölndal, SE;
Maria Astrid Ölwegård-Halvarsson, Mölndal, SE;
Eric Valeur, Mölndal, SE;
William John Drury, III, Mölndal, SE;
Assignees:
ASTRAZENECA AB, Södertälje, SE;
IONIS PHARMACEUTICALS, INC., Carlsbad, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); A61K 31/7125 (2006.01); A61K 31/713 (2006.01); A61K 38/17 (2006.01); A61K 47/54 (2017.01); A61K 47/64 (2017.01); A61K 47/65 (2017.01); C12N 15/11 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6425 (2017.08); A61K 31/7125 (2013.01); A61K 31/713 (2013.01); A61K 38/1796 (2013.01); A61K 47/549 (2017.08); A61K 47/65 (2017.08); C12N 15/111 (2013.01); A61P 35/00 (2018.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/3341 (2013.01); C12N 2310/3513 (2013.01); C12N 2310/3521 (2013.01); C12N 2310/3525 (2013.01); C12N 2310/3533 (2013.01); C12N 2320/32 (2013.01);
Abstract
The present embodiments provide compounds and methods for targeting cells expressing GLP-1 receptor.